ML19217A252: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 15: Line 15:


=Text=
=Text=
{{#Wiki_filter:United States of America Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on the statements and representations herefore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or  
{{#Wiki_filter:EXPORT LICENSE NRC LICENSE NO.: XMAT420/02 United States of America                                                     Page 1 of 3 Nuclear Regulatory Commission                    NRC DOCKET NO.: 11005994 Washington, D.C. 20555 LICENSE EXPIRES: May 31, 2024 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on the statements and representations herefore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.
 
LICENSEE                                      ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)
production or utilization facilities listed below, subject to the terms and conditions herein.
Cambridge Isotope Laboratories, Inc.                                                    See following page(s) 50 Frontage Road Andover, MA 01810 Attn: Gary Ionta INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)                               OTHER U.S. PARTY(IES) TO EXPORT See following page(s)                          Cambridge Isotope Laboratories, Inc.
NRC LICENSE NO.:Page 1 of 3 NRC DOCKET NO.:
50 Frontage Road Andover, MA 01810 (supplier/distributor)
LICENSE EXPIRES:Ma 31, 2024 Nuclear Regulatory CommissionWashington, D.C. 20555 EXPORT LICENSE ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)
INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)OTHER U.S. PARTY(IES) TO EXPORT Neither this license nor any right under this license shall be assigned or otherwise transferred in violation of the provisions of the Atomic EnergyAct of 1954, as amended, and the Energy Reorganization Act of 1974.This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to all the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of
 
THIS LICENSE IS INVALID UNLESS SIGNED BELOWBY AUTHORIZED NRC REPRESENTATIVENAME AND TITLE:
DATE OF ISSUANCE:
APPLICANT'S  
APPLICANT'S  


==REFERENCE:==
==REFERENCE:==
Application dated 03/27/2019              ULTIMATE DESTINATION: Japan QUANTITY(IES)                                    DESCRIPTION OF MATERIAL(S) OR FACILITY(IES)
This license is amended to: 1) include two additional Intermediate consignees, and 2) extend the date of expiration from January 1, 2022 to May 31, 2024.
The licensee is authorized to export a cumulative total of 10,000 kilograms of deuterium, in the form of deuterium oxide, deuterium gas, and other compounds. The cumulative total starts from the issuance of original export license XMAT420.
Neither this license nor any right under this license shall be              THIS LICENSE IS INVALID UNLESS SIGNED BELOW assigned or otherwise transferred in violation of the                            BY AUTHORIZED NRC REPRESENTATIVE provisions of the Atomic Energy Act of 1954, as                                                                    Digitally signed by Peter J.
amended, and the Energy Reorganization Act of 1974.                                            Peter J. Habighorst Habighorst SIGNATURE:                                    Date: 2019.08.02 10:53:24 -04'00' Peter J. Habighorst, Acting Deputy Director This license is subject to the right of recapture or control        NAME AND TITLE:
Office of International Programs by Section 108 of the Atomic Energy Act of 1954, as amended, and to all the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of    DATE OF ISSUANCE:          August 02, 2019 the NRC.
EXPORT LICENSE
XMAT420/02 Page 2 of 3 ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):
: 1.


ULTIMATE DESTINATION:
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
Japan EXPORT LICENSE LICENSEE Cambridge Isotope Laboratories, Inc.50 Frontage Road Andover, M 01810 Attn:Gary Ionta QUANTITY(IES)SIGNATURE:
: 2.  
See following page(s)
See following page(s)
Cambridge Isotope Laboratories, Inc.
50 Frontage Road Andover, MA 01810 (supplier/distributor)DESCRIPTION OF MATERIAL(S) OR FACILITY(IES)
This license is amended to: 1) include two additional consignees, and 2) extend the date of expiration from January 1, 2022 to Ma 31, 2024.
420.Peter J. Habighorst, Acting Deputy DirectorOffice of International Programs XMAT420/02 Page 2 of 3ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):                           


1.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
: 3.


2.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
: 4.


3.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
: 5.


4.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
: 6.


5.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
: 7.


6.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)


7.(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)
XMAT420/02 Page 3 of 3 INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):
XMAT420/02 Page 3 of 3INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):                    
: 1.


1.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 2.


2.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 3.


3.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 4.


4.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 5.


5.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 6.


6.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 7.


7.(for distribution to ultimate consignees)
(for distribution to ultimate consignees)
: 8.


8.(for distribution to ultimate consignees)}}
(for distribution to ultimate consignees)}}

Revision as of 11:37, 19 October 2019

Export License Issued to Cambridge Isotope Laboratories, Inc. XMAT420-02
ML19217A252
Person / Time
Site: 11005994
Issue date: 08/02/2019
From: Peter Habighorst
NRC/OIP
To: Ionta G
Cambridge Isotope Labs
Savoy J
References
Download: ML19217A252 (3)


Text

EXPORT LICENSE NRC LICENSE NO.: XMAT420/02 United States of America Page 1 of 3 Nuclear Regulatory Commission NRC DOCKET NO.: 11005994 Washington, D.C. 20555 LICENSE EXPIRES: May 31, 2024 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on the statements and representations herefore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.

LICENSEE ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)

Cambridge Isotope Laboratories, Inc. See following page(s) 50 Frontage Road Andover, MA 01810 Attn: Gary Ionta INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES) OTHER U.S. PARTY(IES) TO EXPORT See following page(s) Cambridge Isotope Laboratories, Inc.

50 Frontage Road Andover, MA 01810 (supplier/distributor)

APPLICANT'S

REFERENCE:

Application dated 03/27/2019 ULTIMATE DESTINATION: Japan QUANTITY(IES) DESCRIPTION OF MATERIAL(S) OR FACILITY(IES)

This license is amended to: 1) include two additional Intermediate consignees, and 2) extend the date of expiration from January 1, 2022 to May 31, 2024.

The licensee is authorized to export a cumulative total of 10,000 kilograms of deuterium, in the form of deuterium oxide, deuterium gas, and other compounds. The cumulative total starts from the issuance of original export license XMAT420.

Neither this license nor any right under this license shall be THIS LICENSE IS INVALID UNLESS SIGNED BELOW assigned or otherwise transferred in violation of the BY AUTHORIZED NRC REPRESENTATIVE provisions of the Atomic Energy Act of 1954, as Digitally signed by Peter J.

amended, and the Energy Reorganization Act of 1974. Peter J. Habighorst Habighorst SIGNATURE: Date: 2019.08.02 10:53:24 -04'00' Peter J. Habighorst, Acting Deputy Director This license is subject to the right of recapture or control NAME AND TITLE:

Office of International Programs by Section 108 of the Atomic Energy Act of 1954, as amended, and to all the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of DATE OF ISSUANCE: August 02, 2019 the NRC.

EXPORT LICENSE

XMAT420/02 Page 2 of 3 ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):

1.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

2.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

3.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

4.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

5.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

6.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

7.

(non-nuclear end use for distribution in the medical, pharmaceutical, chemical & industrial markets)

XMAT420/02 Page 3 of 3 INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):

1.

(for distribution to ultimate consignees)

2.

(for distribution to ultimate consignees)

3.

(for distribution to ultimate consignees)

4.

(for distribution to ultimate consignees)

5.

(for distribution to ultimate consignees)

6.

(for distribution to ultimate consignees)

7.

(for distribution to ultimate consignees)

8.

(for distribution to ultimate consignees)